G. D. De Socio

发表

Early Treatment with Bamlanivimab Alone does not Prevent COVID-19 Hospitalization and Its Post-Acute Sequelae. A Real Experience in Umbria, Italy

D. Francisci, E. Schiaroli, G. D. De Socio, 2021, Mediterranean journal of hematology and infectious diseases.

Hypertension in HIV patients.

G. Schillaci, G. D. De Socio, 2006, AIDS.

Safety and tolerability of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil fumarate in a real life setting: Data from surveillance cohort long-term toxicity antiretrovirals/antivirals (SCOLTA) project

L. Calza, A. Gori, E. Ricci, 2017, PloS one.

Evaluation of IVD 3.0 Vitek MS matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of Mycobacterium tuberculosis and nontuberculous mycobacteria and its use in routine diagnostics

A. Mencacci, E. Cenci, S. Bozza, 2018, European Journal of Clinical Microbiology & Infectious Diseases.

Clusterization of co-morbidities and multi-morbidities among persons living with HIV: a cross-sectional study

D. Francisci, E. Ricci, P. Bonfanti, 2019, BMC Infectious Diseases.

Tenofovir renal safety in HIV-infected patients: results from the SCOLTA Project.

E. Ricci, P. Bonfanti, T. Quirino, 2008, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

96 Week Follow-Up of HIV-Infected Patients in Rescue with Raltegravir Plus Optimized Backbone Regimens: A Multicentre Italian Experience

M. Meschiari, S. Lo Caputo, E. Ricci, 2012, PloS one.

The use of nucleoside reverse transcriptase inhibitors sparing regimens in treatment-experienced HIV-1 infected patients.

C. Viscoli, E. Ricci, P. Bonfanti, 2013, Current HIV research.

Co-administration of tenofovir plus protease inhibitor based antiretroviral therapy during sofosbuvir/ledipasvir treatment for HCV infection: Much Ado About Nothing?

E. Ricci, P. Bonfanti, L. Taramasso, 2017, Clinics and research in hepatology and gastroenterology.

Dolutegravir Plus Rilpivirine as a Switch Option in cART-Experienced Patients: 96-Week Data

G. Barbarini, S. Di Giambenedetto, A. di Biagio, 2018, The Annals of pharmacotherapy.

Durability of dolutegravir plus boosted darunavir as salvage or simplification of salvage regimens in HIV-1 infected, highly treatment-experienced subjects

G. Barbarini, G. Cenderello, N. Riccardi, 2018, HIV clinical trials.

A dual regimen of ritonavir/darunavir plus dolutegravir for rescue or simplification of rescue therapy: 48 weeks’ observational data

G. Barbarini, G. Cenderello, N. Riccardi, 2017, BMC Infectious Diseases.

Effect of High-Titer Convalescent Plasma on Progression to Severe Respiratory Failure or Death in Hospitalized Patients With COVID-19 Pneumonia

A. d’Arminio Monforte, M. Massari, M. Pistello, 2021, JAMA network open.

Fusobacterium nucleatum endocarditis mimicking polymyalgia rheumatica.

A. Mencacci, G. D. De Socio, M. Pasticci, 2009, Southern medical journal.

Human Papilloma Virus–Associated Lips Verrucous Carcinoma in HIV-Infected Male

S. Simonetti, G. D. De Socio, G. M. Tomassini, 2017, Journal of the International Association of Providers of AIDS Care.

Bone Safety of Dolutegravir-Containing Regimens in People Living with HIV: Results from a Real-World Cohort

E. Ricci, A. De Vito, P. Bonfanti, 2020, Infection and drug resistance.

Use of statins and aspirin to prevent cardiovascular disease among HIV-positive patients. A survey among Italian HIV physicians.

G. Nunnari, A. di Biagio, S. Rusconi, 2017, The new microbiologica.

Premature discard of proton pump inhibitors: possible osteoporosis vs enhanced gastrointestinal bleed, adenocarcinoma efficacy.

M. Massarotti, G. D. De Socio, G. Fabbriciani, 2011, Mayo Clinic proceedings.

Factors Associated With Weight Gain in People Treated With Dolutegravir

L. Calza, E. Ricci, A. Mastroianni, 2020, Open forum infectious diseases.

Lipid profile improvement in virologically suppressed HIV-1-infected patients switched to dolutegravir/abacavir/lamivudine: data from the SCOLTA project

E. Ricci, P. Bonfanti, L. Taramasso, 2019, Infection and drug resistance.

Weight Gain: A Possible Side Effect of All Antiretrovirals

L. Calza, A. Antinori, E. Ricci, 2017, Open forum infectious diseases.

Antiretroviral therapy in geriatric HIV patients: the GEPPO cohort study

G. Guaraldi, A. Malagoli, G. di Perri, 2017, The Journal of antimicrobial chemotherapy.

Measurement and prediction of antimicrobial resistance in bloodstream infections by ESKAPE and Escherichia coli pathogens.

A. Mencacci, E. Cenci, D. Botta, 2019, Journal of global antimicrobial resistance.

Diagnosis of Nocardia paucivorans central nervous system infection by DNA sequencing from paraffin-embedded tissue.

A. Mencacci, F. Baldelli, M. Sanguinetti, 2016, Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive.

Comments on “Real‐world re‐treatment outcomes of direct‐acting antiviral therapy failure in patients with chronic hepatitis C”

K. Falasca, A. Cascio, P. Bonfanti, 2021, Journal of medical virology.

Syphilis as a diagnosis of liver abnormalities in HIV

F. Baldelli, G. D. De Socio, L. Malincarne, 2013, Scandinavian journal of infectious diseases.

Hepatitis C virus genotypes in the liver and serum of patients with chronic hepatitis C.

S. Pauluzzi, D. Francisci, G. D. De Socio, 1996, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

HIV infection and antiretroviral treatment: a "two-hit" model for arterial stiffness?

G. Pucci, G. Schillaci, G. D. De Socio, 2009, American journal of hypertension.

Efavirenz and bone health.

G. D. De Socio, G. Fabbriciani, 2009, AIDS.

Role of Normalized T-Cell Subsets in Predicting Comorbidities in a Large Cohort of Geriatric HIV-Infected Patients

G. Guaraldi, A. Calcagno, A. Cattelan, 2017, Journal of acquired immune deficiency syndromes.

Growing old with antiretroviral therapy or elderly people in antiretroviral therapy: two different profiles of comorbidity?

L. Calza, E. Ricci, G. Cenderello, 2022, BMC Infectious Diseases.

Switch to Dolutegravir plus Rilpivirine Dual Therapy in cART-Experienced Subjects: An Observational Cohort

G. Barbarini, S. Di Giambenedetto, A. di Biagio, 2016, PloS one.

Severe Acute Hepatitis B Treated With Entecavir.

F. Baldelli, G. D. De Socio, A. Tosti, 2011, Mediterranean journal of hematology and infectious diseases.

Entecavir to treat severe acute hepatitis B

F. Baldelli, G. D. De Socio, F. Di Candilo, 2009, Scandinavian journal of infectious diseases.

Symmetric ambulatory arterial stiffness index and 24-h pulse pressure in HIV infection: results of a nationwide cross-sectional study

G. Pucci, G. Schillaci, P. Bonfanti, 2013, Journal of hypertension.

Hypophosphatemic Osteomalacia Associated with Tenofovir: a Multidisciplinary Approach is Required.

M. Massarotti, B. Marasini, G. D. De Socio, 2012, Mediterranean journal of hematology and infectious diseases.

Thrombocytopenia in HIV infected patients. Prevalence and clinical spectrum.

D. Francisci, F. Baldelli, P. Gresele, 1995, Recenti progressi in medicina.

Modelling SARS-CoV-2 unreported cases in Italy: Analysis of serological survey and vaccination scenarios

M. Traini, G. D. De Socio, C. Caponi, 2021, Infectious Disease Modelling.

Malignant syphilis with ocular involvement in an HIV–infected patient

F. Baldelli, S. Simonetti, C. Tomasini, 2011, International journal of STD & AIDS.

AmBisome administration for Candida albicans shunt infections.

G. D. De Socio, G. Stagni, M. Fiorio, 2003, The Journal of antimicrobial chemotherapy.

Acute Cytomegalovirus Meningomyelitis in an Immunocompetent Patient

D. Francisci, G. D. De Socio, M. Fiorio, 1998, European Journal of Clinical Microbiology and Infectious Diseases.

Achromobacter denitrificans renal abscess.

A. Mencacci, F. Baldelli, G. D. De Socio, 2012, The new microbiologica.

Adefovir induced hypophosphatemic osteomalacia

R. Ceriani, M. Massarotti, B. Marasini, 2011, Scandinavian journal of infectious diseases.

Identifying HIV patients with an unfavorable cardiovascular risk profile in the clinical practice: results from the SIMONE study.

G. Schillaci, E. Ricci, P. Bonfanti, 2008, The Journal of infection.

Four years data of raltegravir-based salvage therapy in HIV-1-infected, treatment-experienced patients: the SALIR-E Study.

M. Meschiari, S. Lo Caputo, E. Ricci, 2014, International journal of antimicrobial agents.

A Giant Pancreatic Pseudocyst in a Patient with HIV Infection

F. Baldelli, G. D. De Socio, M. Fischer, 2012, Journal of the International Association of Physicians in AIDS Care.

Effectiveness of first-generation HCV protease inhibitors: does HIV coinfection still play a role?

S. Babudieri, E. Ricci, K. Falasca, 2016, European journal of gastroenterology & hepatology.

Improvement of lipid profile after switching from efavirenz or ritonavir-boosted protease inhibitors to rilpivirine or once-daily integrase inhibitors: results from a large observational cohort study (SCOLTA)

E. Ricci, P. Bonfanti, L. Taramasso, 2018, BMC Infectious Diseases.

Evaluation of the concentrations of psychotropic drugs in HIV-infected versus HIV-negative patients: Potential implications for clinical practice

E. Clementi, A. Giacomelli, D. Cattaneo, 2018, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

National Early Warning Score 2 (NEWS2) better predicts critical Coronavirus Disease 2019 (COVID-19) illness than COVID-GRAM, a multi-centre study

D. Francisci, G. D. De Socio, Anna Gidari, 2021, Infection.

Improving the etiological diagnosis of osteoarticular infections with the commercial multiplex real-time polymerase chain reaction SeptiFast®.

A. Mencacci, S. Bozza, G. D. De Socio, 2020, Diagnostic microbiology and infectious disease.

Relations between cardiovascular risk estimates and subclinical atherosclerosis in naïve HIV patients: results from the HERMES study

P. Vitiello, E. Ricci, P. Bonfanti, 2010, International journal of STD & AIDS.

Lingual tuberculosis: a rare disease in Western countries.

P. Floridi, F. Baldelli, F. Longari, 2012, The new microbiologica.

Causes of HIV Treatment Interruption during the Last 20 Years: A Multi-Cohort Real-Life Study

E. Ricci, A. De Vito, G. Cenderello, 2023, Viruses.

Cerebrospinal fluid penetration of tigecycline

F. Baldelli, G. di Perri, A. D’Avolio, 2014, Scandinavian journal of infectious diseases.

International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK

Raúl Tabarés Gutiérrez, Samit R. Joshi, H. Jessen, 2016, Journal of the International AIDS Society.

Trajectories of CD4+/CD8+ T-Cells Ratio 96 Weeks after Switching to Dolutegravir-Based Two-Drug Regimens: Results from a Multicenter Prospective Cohort Study

E. Ricci, P. Bonfanti, L. Taramasso, 2022, Viruses.

Reversibility of Central Nervous System Adverse Events in Course of Art

E. Ricci, A. Cascio, P. Bonfanti, 2022, Viruses.

Durability of Dolutegravir-Based Regimens: A 5-Year Prospective Observational Study.

L. Calza, E. Ricci, A. De Vito, 2021, AIDS patient care and STDs.

Elderly HIV-positive women: A gender-based analysis from the Multicenter Italian “GEPPO” Cohort

G. Guaraldi, G. di Perri, A. Calcagno, 2019, PloS one.

Smoking habits in HIV-infected people compared with the general population in Italy: a cross-sectional study

D. Francisci, E. Ricci, P. Bonfanti, 2020, BMC Public Health.

Topical cidofovir for severe warts in a patient affected by AIDS and Hodgkin's lymphoma

P. Minga, F. Baldelli, S. Simonetti, 2008, International journal of STD & AIDS.

Positioning of darunavir/cobicistat-containing antiretroviral regimens in real life: results from a large multicentre observational prospective cohort (SCOLTA)

L. Calza, E. Ricci, A. Cascio, 2019, AIDS Research and Therapy.

Safety and durability in a cohort of HIV-1 positive patients treated with once and twice daily darunavir-based therapy (SCOLTA Project).

E. Ricci, P. Bonfanti, A. di Biagio, 2013, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Late onset opportunistic infections in a renal allograft recipient: a case report.

S. Morosi, G. D. De Socio, G. Stagni, 2004, Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive.

Retroperitoneal abscess: an uncommon localization of tubercular infection.

E. Mannarino, G. Schillaci, F. Bistoni, 2008, ˜Le œInfezioni in medicina.

[Renal toxicity in HIV-infected patients receiving HAART including tenofovir].

E. Ricci, P. Bonfanti, T. Quirino, 2006, Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive.

Partial Achievement of the 90-90-90 UNAIDS Target in a Cohort of HIV Infected Patients from Central Italy

D. Francisci, F. Baldelli, C. Papalini, 2020, Mediterranean journal of hematology and infectious diseases.

Prevalence, awareness, treatment, and control rate of hypertension in HIV-infected patients: the HIV-HY study.

L. Calza, G. Pucci, G. Schillaci, 2014, American journal of hypertension.

Laboratory automation reduces time to report of positive blood cultures and improves management of patients with bloodstream infection

A. Mencacci, E. Cenci, G. D. De Socio, 2018, European Journal of Clinical Microbiology & Infectious Diseases.

Tuberculosis After Gastrectomy, Plasmatic Concentration of Antitubercular Drugs

F. Baldelli, G. di Perri, A. D’Avolio, 2012, Mediterranean journal of hematology and infectious diseases.

Smoking habits in HIV-infected people from Italy: a cross-sectional analysis of the STOPSHIV cohort.

D. Francisci, E. Ricci, P. Bonfanti, 2019, AIDS research and human retroviruses.

Is it feasible to impact on smoking habits in HIV-Infected patients? Mission impossible from the STOPSHIV Project cohort.

D. Francisci, E. Ricci, P. Bonfanti, 2020, Journal of acquired immune deficiency syndromes.

Modeling the asymptomatic prevalence of SARS-CoV-2 epidemic in Italy and the ISTAT survey

G. D. De Socio, Riccardo Ferrari, Marco Claudio Traini, 2021, medRxiv.

Decreasing cardiovascular risk in HIV infection between 2005 and 2011

G. Pucci, G. Schillaci, E. Ricci, 2014, AIDS.

Statins and aspirin in the prevention of cardiovascular disease among HIV-positive patients between controversies and unmet needs: review of the literature and suggestions for a friendly use

G. d’Ettorre, G. Nunnari, A. di Biagio, 2019, AIDS Research and Therapy.

Lipids and transaminase elevations in ARV-experienced PLWH switching to a doravirine-based regimen from rilpivirine or other regimens

E. Ricci, K. Falasca, A. Cascio, 2023, BMC Infectious Diseases.

The Effect of Switching from Tenofovir Disoproxil Fumarate (TDF) to Tenofovir Alafenamide (TAF) on Liver Enzymes, Glucose, and Lipid Profile

E. Ricci, K. Falasca, P. Bonfanti, 2020, Drug design, development and therapy.

Is estimated cardiovascular risk higher in HIV-infected patients than in the general population?

G. Schillaci, S. Morosi, G. D. De Socio, 2007, Scandinavian journal of infectious diseases.

Chronological and biological age in HIV infection.

E. Ricci, P. Bonfanti, G. Parruti, 2010, The Journal of infection.

Laboratory automation reduces time to report of positive blood cultures and improves management of patients with bloodstream infection

A. Mencacci, E. Cenci, G. D. De Socio, 2018, European Journal of Clinical Microbiology & Infectious Diseases.

Dolutegravir is not associated with weight gain in antiretroviral therapy experienced geriatric patients living with HIV

S. Calza, J. Milic, G. Guaraldi, 2021, AIDS.

Adherence to antiretroviral therapy in HIV patients with psychiatric comorbidity.

G. D. De Socio, G. Stagni, L. Fanelli, 2004, Journal of acquired immune deficiency syndromes.

Cardiovascular risk assessment in antiretroviral-naïve HIV patients.

E. Ricci, P. Bonfanti, T. Quirino, 2009, AIDS patient care and STDs.

Aortic Stiffness in Untreated Adult Patients With Human Immunodeficiency Virus Infection

E. Mannarino, G. Pucci, G. Schillaci, 2008, Hypertension.

Negative Influence of HIV Infection on Day-Night Blood Pressure Variability

P. Vitiello, G. Pucci, G. Schillaci, 2010, Journal of acquired immune deficiency syndromes.

Laboratory automation, informatics, and artificial intelligence: current and future perspectives in clinical microbiology

A. Mencacci, E. Cenci, G. D. De Socio, 2023, Frontiers in Cellular and Infection Microbiology.

Modelling the epidemic 2019-nCoV event in Italy: a preliminary note

M. Traini, G. D. De Socio, Marco Claudio Traini, 2020, medRxiv.

Predictive value of National Early Warning Score 2 (NEWS2) for intensive care unit admission in patients with SARS-CoV-2 infection

D. Francisci, S. Sabbatini, G. D. De Socio, 2020, Infectious diseases.

Switch to dolutegravir and unboosted atazanavir in HIV-1 infected patients with undetectable viral load and long exposure to antiretroviral therapy

A. Riva, L. Galli, S. Di Giambenedetto, 2019, AIDS.

Impact of Treatment With Protease Inhibitors on Aortic Stiffness in Adult Patients With Human Immunodeficiency Virus Infection

E. Mannarino, G. Schillaci, F. Baldelli, 2005, Arteriosclerosis, thrombosis, and vascular biology.

A study of SARS-CoV-2 epidemiology in Italy: from early days to secondary effects after social distancing

M. Traini, G. D. De Socio, Riccardo Ferrari, 2020, Infectious diseases.

A study of SARS-CoV-2 evolution in Italy: from early days to secondary effects after social distancing

M. Traini, G. D. De Socio, Riccardo Ferrari, 2020, medRxiv.

The feature of Metabolic Syndrome in HIV naive patients is not the same of those treated: results from a prospective study.

A. Antinori, E. Ricci, P. Bonfanti, 2012, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Switch from unboosted protease inhibitor to a single-tablet regimen containing rilpivirine improves cholesterol and triglycerides.

P. Vitiello, C. Viscoli, A. Signori, 2016, International journal of antimicrobial agents.

Accelerate Pheno™ system in sepsis by Gram-negative pathogens: four months of hospital experience.

A. Mencacci, E. Cenci, D. Francisci, 2020, The new microbiologica.

Metabolic Syndrome: A Real Threat for HIV-Positive Patients?: Results from the SIMONE Study

E. Ricci, P. Bonfanti, G. Parruti, 2006, Journal of acquired immune deficiency syndromes.

Metabolic syndrome and body weight in people living with HIV infection: analysis of differences observed in three different cohort studies over a decade

D. Francisci, E. Ricci, P. Bonfanti, 2021, HIV medicine.

Lipids and Transaminase in Antiretroviral-Treatment-Experienced People Living with HIV, Switching to a Doravirine-Based vs. a Rilpivirine-Based Regimen: Data from a Real-Life Setting

L. Calza, R. Bellagamba, E. Ricci, 2023, Viruses.

A. Mencacci, E. Cenci, S. Bozza, 2018, European Journal of Clinical Microbiology & Infectious Diseases.

Accuracy and Impact on Patient Management of New Tools for Diagnosis of Sepsis: Experience with the T2 Magnetic Resonance Bacteria Panel

A. Mencacci, E. Cenci, B. Camilloni, 2021, Pathogens.

Lack of HIV seroconversion in a patient treated immediately with antiretroviral therapy at acute infection and virus relapse.

M. Zazzi, G. Marchetti, D. Francisci, 2021, AIDS.

Acute meningoencephalitis in chronic HIV infection: clinical resolution with lopinavir-ritonavir-containing therapy.

M. Zazzi, F. Baldelli, G. D. De Socio, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Observed versus predicted cardiovascular events and all-cause death in HIV infection: a longitudinal cohort study

G. Pucci, G. Schillaci, F. Baldelli, 2017, BMC Infectious Diseases.

Statins and Aspirin use in HIV-infected people: gap between European AIDS Clinical Society guidelines and clinical practice: the results from HIV-HY study

L. Calza, E. Ricci, P. Bonfanti, 2016, Infection.

Time trend in hypertension prevalence, awareness, treatment, and control in a contemporary cohort of HIV-infected patients: the HIV and Hypertension Study

G. Pucci, G. Schillaci, E. Ricci, 2017, Journal of hypertension.

Real-life safety of Emtricitabine/Tenofovir Alafenamide/Bictegravir

E. Ricci, G. Cenderello, K. Falasca, 2023, PloS one.

Delivery in Asymptomatic Italian Woman with SARS-CoV-2 Infection

A. Mencacci, D. Francisci, B. Camilloni, 2020, Mediterranean journal of hematology and infectious diseases.

Dolutegravir/Lamivudine versus Tenofovir Alafenamide/Emtricitabine/Bictegravir as a Switch Strategy in a Real-Life Cohort of Virogically Suppressed People Living with HIV

G. D. De Socio, Anna Gidari, Daniela Francisci, 2023, Journal of Clinical Medicine.

Pre and Post-Monoclonal Infusion Neutralizing Activity in a Subgroup of Patients Treated in the Presence of two SARS-CoV-2 Dominant Variant of Concern (VOCs) and an Ongoing Vaccination. Overall Clinical Efficacy of Two Monoclonal Antibodies Association in Umbria

M. Zazzi, S. Benedetti, D. Francisci, 2022, Mediterranean journal of hematology and infectious diseases.